Skip to Main Content

Paper Details

Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.
Nat Commun
5
2020
Author NameAffiliation
Kentaro OharaKeio University School of Medicine
  • 1 - 1

Datasets

Release 1.2